Inhibitor-Protected Aminopenicillins. Pharmacological Characterization and Role in Community-Acquired Infections

Inhibitor-Protected Aminopenicillins. Pharmacological Characterization and Role in Community-Acquired Infections

Saved in:

Bibliographic Details
Main Authors:	I. A. Guchev, E. V. Melehina
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/254
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness of protected aminopenicillins in treatment of non-social pneumonia in children
by: E. E. Krasnova, et al.
Published: (2021-11-01)

Prophylaxis of Community-Acquired Pneumonia Outbreaks with Pneumococcal Polysaccharide Vaccine. Prospects Analysis for Russian Military Community
by: I. A. Guchev, et al.
Published: (2020-05-01)

Council of Experts Resolution on the Use of Inhibitor-Protected Beta-Lactams in the Treatment of Community-Acquired and Nosocomial Infections 11 February , 2019, Moscow
by: A. V. Alekhin, et al.
Published: (2020-05-01)

The role of anticoagulants in the treatment of community-acquired pneumonia in patients combined with coronavirus infection
by: I. M. Fushtei, et al.
Published: (2025-02-01)

Platelet variables in community-acquired pneumonia in children with respiratory infections
by: E. A. Kozyrev, et al.
Published: (2022-04-01)

Characterization of the oxidative metabolism of erythrocytes in patients with community-acquired pneumonia
by: L. A. Demidchik, et al.
Published: (2016-05-01)

Predictors and etiology of healthcare-associated infections in patients with severe community-acquired pneumonia
by: I. A. Ruslyakova, et al.
Published: (2025-02-01)

Phenotypic Detection of Extended-Spectrum β-lactamases (ESBLs) and Aminopenicillin Cephalosporinase (AmpC)-Producing Bacterial Isolates from Surfaces of Hospital Fomites and Hands of Healthcare Workers
by: Musa Y. Tula1*, et al.
Published: (2023-09-01)

The Role of Ultrasound in Diagnosing Community-Acquired Pneumonia
by: D. O. Starostin, et al.
Published: (2023-02-01)

Community-acquired pneumonia in HIV patients
by: I. B. Viktorova, et al.
Published: (2021-05-01)

Characterizing and Developing Strategies for the Treatment of Community-Acquired Pneumonia at a Community Hospital
by: Mark C Fok, et al.
Published: (2002-01-01)

SPHINGOMONAS PAUCIMOBILIS INFECTIONS IN CHILDREN: NOSOCOMIAL VERSUS COMMUNITY ACQUIRED INFECTIONS
by: Nuri Bayram, et al.
Published: (2013-06-01)

Rational Etiotropic Treatment of Upper Respiratory Tract Infections. Problems of Antibiotic Resistance of Community-Acquired Infections
by: I. A. Karpov, et al.
Published: (2020-05-01)

Physiology, pharmacology and prospects for dipeptidilpeptidase-4 inhibitors use
by: D. V. Kurkin, et al.
Published: (2023-05-01)

Levofloxacin. Expediency of High-Dose Regimens in Therapy of Lower Respiratory Tract Infections
by: I. A. Guchev, et al.
Published: (2020-05-01)

Comprehensive treatment of patients with community-acquired pneumonia
by: N. E. Chernekhovskaya, et al.
Published: (2019-07-01)

Pharmacogenetics of Community-Acquired Pneumonia
by: S. SH. Suleimanov, et al.
Published: (2020-05-01)

Spiramycin: The past and future of an antibiotic with pleiotropic effects in the therapy of community-acquired infections
by: O. I. Butranova, et al.
Published: (2024-11-01)

Immunological aspects of cytomegalovirus infection in community-acquired pneumonia among young adults.
by: K. D. Chichirelo-Konstantynovych, et al.
Published: (2018-04-01)

Pharmacology of modern ACE inhibitors: moexipril example
by: D. P. Khloponin, et al.
Published: (2007-10-01)

Novelties in the treatment of community-acquired and hospital-acquired pneumonia
by: Matteo Bassetti, et al.
Published: (2025-04-01)

Role of eIF6 in Modulating Response to BRAF Inhibitors and Acquired Resistance in Cutaneous Melanoma
by: G. Kyriakopoulos, et al.
Published: (2024-01-01)

Clinical recommendations for antibacterial therapy of community-acquired infections: what should a practitioner pay attention to?
by: I. V. Кovaleva
Published: (2025-05-01)

Gender and Age-Dependent Etiology of Community-Acquired Urinary Tract Infections
by: Enrico Magliano, et al.
Published: (2012-01-01)

Prevalence and molecular characterization of ESBL-producing Enterobacteriaceae in Egypt: a systematic review and meta-analysis of hospital and community-acquired infections
by: Ahmed Azzam, et al.
Published: (2024-12-01)

Retrospective Analysis of the Safety of Antibacterial Medicinal Products for Elderly Patients with Community-Acquired Lower Respiratory Tract Infections
by: G. I. Gorodetskaya, et al.
Published: (2023-03-01)

PHARMACOLOGICAL CARDIAC PROTECTION: WHAT IS NEW?
by: I. A. Kozlov
Published: (2019-05-01)

Characterization and pharmacological properties of a novel multifunctional Kunitz inhibitor from Erythrina velutina seeds.
by: Richele J A Machado, et al.
Published: (2013-01-01)

Manifestations of the Epidemic Process of Community-Acquired Pneumonia among HIV-Infected Patients and Dependence of Incidence of Infection on the Level of Immunodeficiency and Viral Load
by: V. I. Sergevnin, et al.
Published: (2022-05-01)

Epidemiological features of community-acquired mycoplasma pneumonia
by: E. A. Koshkarina, et al.
Published: (2021-09-01)

Role of Chlamydia pneumoniae in community-acquired pneumonia in hospitalized Jordanian adults
by: Suzan N Al-Aydie, et al.
Published: (2016-03-01)

Тhe features of severe community acquired pneumonia
by: Avramenko I.V.
Published: (2015-06-01)

Mycoplasma pneumoniae infection in hospitalized adult patients with community-acquired pneumonia in China
by: Zongxiao Shangguan, et al.
Published: (2014-10-01)

Community-acquired urinary tract infections: Causative agents and their resistance to antimicrobial drugs
by: Đorđević Zorana, et al.
Published: (2016-01-01)

Current Issues of Empirical Therapy of Severe Bacterial Community-Acquired Pneumonia During the Season of Respiratory Viral Infections
by: V. B. Beloborodov, et al.
Published: (2020-12-01)

Features of laboratory indicators of severe community-acquired pneumonia.
by: T. A. Pertzeva, et al.
Published: (2017-06-01)

The Etiological Structure and Antibiotic Resistance of Pathogens of Community-Acquired Infections of the Urinary Tract in St. Petersburg, 2013-2015
by: O. A. Kameneva, et al.
Published: (2020-05-01)

Vaccinal Prevention of Lower Respiratory Tract Pneumococcal Disease in Adults Without Immunosuppression
by: I. A. Guchev
Published: (2020-05-01)

Etiological Structure of Community-Acquired Pneumonia in the period of COVID-19 epidemic
by: V. I. Sergevnin, et al.
Published: (2024-03-01)

HOSPITAL-ACQUIRED URINARY TRACT INFECTIONS IN CANCER PATIENTS
by: N. V. Dmitrieva, et al.
Published: (2017-12-01)